KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    MITOCHONDRIAL OXIDATIVE STRESS AND BIOGENESIS DURING ACETAMINOPHEN HEPATOTOXICITY

    Thumbnail
    View/Open
    DU_ku_0099D_15125_DATA_1.pdf (3.681Mb)
    Issue Date
    2017-05-31
    Author
    Du, Kuo
    Publisher
    University of Kansas
    Format
    193 pages
    Type
    Dissertation
    Degree Level
    Ph.D.
    Discipline
    Pharmacology, Toxicology & Therapeutics
    Rights
    Copyright held by the author.
    Metadata
    Show full item record
    Abstract
    Acetaminophen (APAP) overdose causes severe hepatotoxicity in animals and humans. Although numerous studies have established the existence of an extensive oxidative stress during APAP hepatotoxicity, its source, pathophysiological roles and therapeutic potentials have not been well clarified. In addition, little is known about the mechanisms of recovery of mitochondrial mass and function or the role of mitochondrial biogenesis (MB) in the injury and repair process. The primary purpose of this dissertation was to further investigate the role of mitochondria, especially mitochondrial oxidative stress and MB, in APAP hepatotoxicity. In the first study, we explored the mechanisms underlying the gender differences in susceptibility to APAP overdose in mice. We demonstrated that female mice are less susceptible to APAP hepatotoxicity. The lower susceptibility of female mice was achieved by the improved detoxification of reactive oxygen due to accelerated recovery of mitochondrial GSH levels, which attenuates late JNK activation and oxidant stress. However, even the reduced injury in female mice was still dependent on c-Jun N-terminal kinase (JNK). In the second study, we tested the therapeutic potential of targeting mitochondrial oxidant stress. We showed that mitochondria-targeted antioxidant Mito-Tempo (MT) protected against APAP hepatotoxicity in mice. It did not inhibit metabolic activation of APAP but dose-dependently attenuated mitochondrial oxidant stress and prevented the following mitochondrial dysfunction. Comparison of the protection by MT to its analog Tempo highlights the importance of mitochondrial oxidant stress in the development of APAP toxicity. Our study also demonstrated that MT as a treatment alone or together with NAC offers a better protection than NAC alone, which supports MT as a therapeutic option for APAP overdosed patients. In the third study, we demonstrated that metformin, a first-line drug to treat type 2 diabetes mellitus, protected against APAP hepatotoxicity in mice. It did not inhibit JNK activation or mitochondrial JNK translocation but significantly attenuated APAP-induced mitochondrial oxidant stress and the subsequent mitochondrial dysfunction, most likely through inhibition of mitochondrial complex I activity. In addition, metformin dose-dependently protected human HepaRG cells, a clinically relevant model for APAP overdose, against APAP induced cell injury, supporting metformin as a therapeutic option for treatment of APAP overdose or acute liver failure in patients. In the last study, we investigated the role of MB after APAP overdose. We demonstrated that MB occurs selectively in hepatocytes surrounding necrotic areas after APAP hepatotoxicity. While induction of MB protected against the injury and promoted liver regeneration, its inhibition delayed the injury and compromised the regeneration process. Induction of MB may be another promising therapeutic approach for clinical APAP overdose in the future. In summary, this dissertation further demonstrates that mitochondrial oxidant stress and dysfunction play a critical role in APAP hepatotoxicity, and targeting mitochondrial oxidant stress and MB can be promising therapeutic approaches for patients with APAP overdose.
    URI
    http://hdl.handle.net/1808/26928
    Collections
    • Pharmacy Dissertations and Theses [118]
    • Dissertations [4472]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps